Table of Contents Author Guidelines Submit a Manuscript
Veterinary Medicine International
Volume 2017, Article ID 1757059, 6 pages
https://doi.org/10.1155/2017/1757059
Research Article

Status Epilepticus due to Intraperitoneal Injection of Vehicle Containing Propylene Glycol in Sprague Dawley Rats

1Advanced Platform Technology Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, 10701 East Blvd, 151 W/APT, Cleveland, OH 44106, USA
2Department of Biomedical Engineering, Case Western Reserve University, 2071 Martin Luther King Jr. Drive, Wickenden Bldg., Cleveland, OH 44106, USA

Correspondence should be addressed to Evon S. Ereifej; moc.liamg@jefieree

Received 4 April 2017; Accepted 11 June 2017; Published 12 July 2017

Academic Editor: George Stoica

Copyright © 2017 Evon S. Ereifej et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Y. Lim, R. L. Poole, and N. M. Pageler, “Propylene glycol toxicity in children,” J Pediatr Pharmacol Ther, vol. 19, no. 4, pp. 277–282, 2014. View at Google Scholar
  2. A. Kulo, A. Smits, G. Naulaers, J. De Hoon, and K. Allegaert, “Biochemical tolerance during low dose propylene glycol exposure in neonates: a formulation-controlled evaluation,” DARU, Journal of Pharmaceutical Sciences, vol. 20, no. 1, no. 5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. K. C. Wilson, C. Reardon, A. C. Theodore, and H. W. Farber, “Propylene glycol toxicity: A severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study,” Chest, vol. 128, no. 3, pp. 1674–1681, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. F. Gaunt, F. M. B. Carpanini, P. Grasso, and A. B. G. Lansdown, “Long-term toxicity of propylene glycol in rats,” Food and Cosmetics Toxicology, vol. 10, no. 2, pp. 151–162, 1972. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Ruddick, “Toxicology, metabolism, and biochemistry of 1,2-propanediol,” Toxicology and Applied Pharmacology, vol. 21, no. 1, pp. 102–111, 1972. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. Clark and M. H. Litchfield, “The toxicity, metabolism, and pharmacologic properties of propylene glycol 1,2-dinitrate,” Toxicology and Applied Pharmacology, vol. 15, no. 1, pp. 175–184, 1969. View at Publisher · View at Google Scholar · View at Scopus
  7. B. J. Barnes, C. Gerst, J. R. Smith, A. R. Terrell, and M. E. Mullins, “Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation,” Pharmacotherapy, vol. 26, no. 1, pp. 23–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Nelsen, C. E. Haas, B. Habtemariam et al., “A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients,” Journal of Intensive Care Medicine, vol. 23, no. 3, pp. 184–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Chen, Y. Chen, J. H. Lin, J. M. Wu, and S. H. Tseng, “Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound,” Anticancer Research, vol. 26, no. 2A, pp. 1237–1245, 2006. View at Google Scholar
  10. J. H. Jeong, Y. R. Lee, H. G. Park, and W. L. Lee, “The effects of either resveratrol or exercise on macrophage infiltration and switching from M1 to M2 in high fat diet mice,” The Journal of Exercise Nutrition and Biochemistry, vol. 6, no. 1, pp. 65–72, 1975. View at Publisher · View at Google Scholar
  11. M. M. Oh, J. M. Power, L. T. Thompson, and J. F. Disterhoft, “Caution against using propylene glycol as a solvent in epilepsy drug research,” Neuroscience Research Communications, vol. 27, no. 2, pp. 117–124, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. L. Beckman and D. J. Crittenden, “Protection from Oxygen-Induced Seizures by Clonazepam and Propylene Glycol (41232),” Proceedings of the Society for Experimental Biology and Medicine, vol. 168, no. 1, pp. 45–48, 1981. View at Publisher · View at Google Scholar · View at Scopus
  13. B. W. M. M. Peeters, K. S. Cheung, J. M. H. Vossen, and A. M. L. Coenen, “Some solvents for antiepileptics have proepileptic potencies in the WAG/Rij rat model for absence epilepsy,” Brain Research Bulletin, vol. 29, no. 3-4, pp. 515–517, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bulathsinghala, K. Keefer, and A. Van De Louw, “Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis,” Medicine (United States), vol. 95, no. 17, Article ID e3478, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Fowles, M. I. Banton, and L. H. Pottenger, “A toxicological review of the propylene glycols,” Critical Reviews in Toxicology, vol. 43, no. 4, pp. 363–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. A. J. Speth, T. B. Vree, N. F. Neilen et al., “Propylene glycol pharmacokinetics and effects after intravenous infusion in humans,” Therapeutic Drug Monitoring, vol. 9, no. 3, pp. 255–258, 1987. View at Publisher · View at Google Scholar · View at Scopus
  17. “NTP-CERHR Expert Panel report on the reproductive and developmental toxicity of propylene glycol,” Reproductive Toxicology, vol. 18, no. 4, pp. 533–579, 2004. View at Publisher · View at Google Scholar
  18. J.-F. Cloix and T. Hévor, “Epilepsy, regulation of brain energy metabolism and neurotransmission,” Current Medicinal Chemistry, vol. 16, no. 7, pp. 841–853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. K. Hevor, P. Delorme, and J. C. Beauvillain, “Glycogen synthesis and immunocytochemical study of fructose-1,6-biphosphatase in methionine sulfoximine epileptogenic rodent brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 6, no. 3, pp. 292–297, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. P. E. Schauwecker, “The effects of glycemic control on seizures and seizure-induced excitotoxic cell death,” BMC Neuroscience, vol. 13, no. 1, article no. 94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Glasgow, R. L. Boeckx, M. K. Miller, M. G. MacDonald, G. P. August, and S. I. Goodman, “Hyperosmolality in small infants due to propylene glycol,” Pediatrics, vol. 72, no. 3, pp. 353–355, 1983. View at Google Scholar · View at Scopus
  22. M. G. MacDonald, “Propylene glycol: increased incidence of seizures in low birth weight infants,” Pediatrics, vol. 79, no. 4, p. 622, 1987. View at Google Scholar
  23. L. Hansen, R. Lange, and S. Gupta, “Development and evaluation of a guideline for monitoring propylene glycol toxicity in pediatric intensive care unit patients receiving continuous infusion lorazepam,” The Journal of Pediatric Pharmacology and Therapeutics, vol. 20, no. 5, pp. 367–372, 2015. View at Google Scholar
  24. G. Martin and L. Finberg, “Propylene glycol: a potentially toxic vehicle in liquid dosage form,” The Journal of Pediatrics, vol. 77, no. 5, pp. 877-878, 1970. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Arulanantham and M. Genel, “Central nervous system toxicity associated with ingestion of propylene glycol,” Journal of Pediatrics, vol. 93, no. 3, pp. 515-516, 1978. View at Publisher · View at Google Scholar · View at Scopus
  26. O. L. Hung and L. Nelson, Tintinalli's Emergency Medicine: A Comprehensive Study Guide, McGraw-Hill, New York, NY, USA, 2004.
  27. K. A. Tuohy, W. J. Nicholson, and F. Schiffman, “Agitation by sedation,” Lancet, vol. 361, no. 9354, p. 308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Kelner and D. N. Bailey, “Propylene glycol as a cause of lactic acidosis,” Journal of Analytical Toxicology, vol. 9, no. 1, pp. 40–42, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. J. O'Donnell, S. L. Mertl, and W. N. Kelly, “Propylene glycol toxicity in a pediatric patient: the dangers of diluents,” Journal of Pharmacy Practice, vol. 13, no. 3, pp. 214–225, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Spector, Handbook of Toxicology Vol 1 Acute Toxicities of Solds, Liquids and Gases to Laboratory Animals, Saunders, 1956.
  31. J. F. Turrens, J. Lariccia, and M. G. Nair, “Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats,” Free Radical Research, vol. 27, no. 6, pp. 557–562, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-H. Tseng, S.-M. Lin, J.-C. Chen et al., “Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats,” Clinical Cancer Research, vol. 10, no. 6, pp. 2190–2202, 2004. View at Publisher · View at Google Scholar · View at Scopus